ANI Pharmaceuticals (ANIP)

[Jon20ABX]

lltd,

If an NDA is submitted or resubmitted to the FDA it's a material event for a publically traded company. The NDA submission fee alone is north of $2M. And waaaaaay before that's even a possibility, trials would have to be conducted which would also be material and have to be disclosed due to the high costs. The government clinical trial site would also reveal whatever trials are taking place. Short answer is a public company can't mask these activities.

I know what I heard IR tell me. What I heard was that nothing was going on with anything "testosterone". Once I saw that all three patents had been abandoned, that was ANIP telling the world that there is nothing going on.

Can people keep speculating on this? Sure, but the elements needed to support any sort of hypothesis have all but disappeared. It appears to me that libigel has now become a subject from which ANIP would like to distance themselves. It's a shame that more trial work wasn't done as I do believe there is merit to the drug, but my vote doesn't count with FDA trial review teams. The placebo effect can be very powerful, and this has shown to be true with other drugs under review. Still, at this point, it is what it is.